In this issue
Community pharmacists' contribution to public health: assessing the global evidence baseSubscription
In the UK, community pharmacies are more accessible to the general population than general practices. Therefore, government white papers and briefing documents from pharmacy professional bodies have advocated the expansion of the role of community pharmacists, particularly in relation to the provision of services that contribute to disease prevention and health improvement. It is unknown whether the same evidence exists globally for the expansion of these roles. This article attempts ...
Glucose-lowering drugs and cardiovascular risk: how recent outcome trials have informed practiceSubscription
Although large clinical trials with glucose-lowering drugs have consistently shown beneficial reductions in microvascular complications, their effects on macrovascular complications have been controversial. Interpreting these trials is complicated by substantial differences in their design, the populations studied and data analysis. This article examines how the trials have evolved and how they impact the use of glucose-lowering agents in the routine care of patients with type ...
How does the technology giant’s marketing approach relate to person-centred care in health?
As one of the most common paediatric psychiatric disorders, pharmacists and healthcare professionals need to be aware of the symptoms of depression and be able to assess children and young people who may be at risk.
The NHS must provide an integrated cancer service, particularly because improvements in diagnosis and treatment position the management of many cancers similarly to other long-term conditions,
The contraceptive pill, a convenient and effective method for women to control their fertility, has been trumpeted as a major development of the modern world. Nearly 800 million married or in-union women of reproductive age are expected to be using contraception by 2030 worldwide